Cape Ann Savings Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $757K | Sell |
3,008
-100
| -3% | -$21.5K | 0.36% | 59 |
|
|
2026
Q1 | $676K | Buy |
3,108
+10
| +0.3% | +$2.22K | 0.34% | 60 |
|
|
2025
Q4 | $708K | Buy |
3,098
+110
| +4% | +$25.1K | 0.36% | 57 |
|
|
2025
Q3 | $692K | Sell |
2,988
-150
| -5% | -$30.5K | 0.37% | 53 |
|
|
2025
Q2 | $582K | Sell |
3,138
-125
| -4% | -$23.2K | 0.35% | 55 |
|
|
2025
Q1 | $684K | Sell |
3,263
-98
| -3% | -$19.1K | 0.43% | 51 |
|
|
2024
Q4 | $597K | Sell |
3,361
-215
| -6% | -$39.5K | 0.35% | 55 |
|
|
2024
Q3 | $706K | Sell |
3,576
-437
| -11% | -$81.6K | 0.41% | 53 |
|
|
2024
Q2 | $688K | Sell |
4,013
-4,693
| -54% | -$777K | 0.43% | 52 |
|
|
2024
Q1 | $1.59M | Sell |
8,706
-3,747
| -30% | -$646K | 0.99% | 28 |
|
|
2023
Q4 | $2.05M | Sell |
12,453
-40
| -0.3% | -$5.83K | 1.35% | 20 |
|
|
2023
Q3 | $1.86M | Sell |
12,493
-140
| -1% | -$20.6K | 1.31% | 19 |
|
|
2023
Q2 | $1.7M | Buy |
12,633
+299
| +2% | +$43.8K | 1.13% | 23 |
|
|
2023
Q1 | $1.97M | Buy |
12,334
+87
| +0.7% | +$13.3K | 1.38% | 20 |
|
|
2022
Q4 | $1.98M | Sell |
12,247
-309
| -2% | -$47.4K | 1.45% | 18 |
|
|
2022
Q3 | $1.69M | Buy |
12,556
+226
| +2% | +$32.4K | 1.35% | 21 |
|
|
2022
Q2 | $1.89M | Buy |
12,330
+323
| +3% | +$49.4K | 1.45% | 19 |
|
|
2022
Q1 | $1.95M | Sell |
12,007
-3,110
| -21% | -$452K | 1.28% | 23 |
|
|
2021
Q4 | $2.05M | Buy |
15,117
+3,438
| +29% | +$406K | 1.23% | 21 |
|
|
2021
Q3 | $1.26M | Buy |
11,679
+3,644
| +45% | +$416K | 0.82% | 34 |
|
|
2021
Q2 | $905K | Buy |
8,035
+473
| +6% | +$53.3K | 0.57% | 44 |
|
|
2021
Q1 | $818K | Sell |
7,562
-30
| -0.4% | -$3.21K | 0.58% | 45 |
|
|
2020
Q4 | $813K | Buy |
+7,592
| New | +$730K | 0.59% | 43 |
|
|
2020
Q2 | $854K | Buy |
+8,695
| New | +$766K | 0.72% | 39 |
|
|
2019
Q3 | $507K | Sell |
6,696
-1,105
| -14% | -$75.8K | 0.59% | 42 |
|
|
2019
Q2 | $568K | Sell |
7,801
-119
| -2% | -$9.35K | 0.66% | 37 |
|
|
2019
Q1 | $638K | Hold |
7,920
| – | – | 0.76% | 37 |
|
|
2018
Q4 | $638K | Sell |
7,920
-530
| -6% | -$46.6K | 0.78% | 38 |
|
|
2018
Q3 | $799K | Hold |
8,450
| – | – | 0.94% | 35 |
|
|
2018
Q2 | $760K | Buy |
+8,450
| New | +$825K | 0.95% | 35 |
|
|
2017
Q4 | $847K | Buy |
+8,760
| New | +$826K | 1.07% | 32 |
|
|
2017
Q2 | $650K | Buy |
8,964
+1,050
| +13% | +$70.6K | 0.86% | 35 |
|
|
2017
Q1 | $516K | Hold |
7,914
| – | – | 0.69% | 39 |
|
|
2016
Q4 | $484K | Buy |
7,914
+73
| +0.9% | +$4.46K | 0.68% | 39 |
|
|
2016
Q3 | $495K | Sell |
7,841
-543
| -6% | -$35.2K | 0.7% | 40 |
|
|
2016
Q2 | $519K | Buy |
8,384
+305
| +4% | +$18.6K | 0.71% | 38 |
|
|
2016
Q1 | $461K | Buy |
8,079
+90
| +1% | +$5.02K | 0.64% | 43 |
|
|
2015
Q4 | $474K | Buy |
7,989
+124
| +2% | +$7.14K | 0.65% | 43 |
|
|
2015
Q3 | $428K | Hold |
7,865
| – | – | 0.64% | 46 |
|
|
2015
Q2 | $528K | Buy |
7,865
+320
| +4% | +$20.9K | 0.75% | 43 |
|
|
2015
Q1 | $442K | Buy |
7,545
+470
| +7% | +$28.4K | 0.62% | 48 |
|
|
2014
Q4 | $463K | Hold |
7,075
| – | – | 0.67% | 48 |
|
|
2014
Q3 | $409K | Buy |
7,075
+180
| +3% | +$9.99K | 0.61% | 53 |
|
|
2014
Q2 | $389K | Hold |
6,895
| – | – | 0.56% | 54 |
|
|
2014
Q1 | $354K | Hold |
6,895
| – | – | 0.58% | 50 |
|
|
2013
Q4 | $364K | Sell |
6,895
-455
| -6% | -$22.4K | 0.59% | 51 |
|
|
2013
Q3 | $329K | Sell |
7,350
-2,632
| -26% | -$117K | 0.56% | 52 |
|
|
2013
Q2 | $412K | Buy |
+9,982
| New | +$437K | 0.69% | 48 |
|
Other funds holding ABBV
Cape Ann Savings Bank's ABBV Position: Q2 2026 in Review
Cape Ann Savings Bank reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $21.5K and leaving 3,008 shares worth $757K. The position accounts for 0.36% of the portfolio, ranked #59.
Cape Ann Savings Bank first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.05M in Q4 2023. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cape Ann Savings Bank held 3,008 shares of AbbVie worth $757K as of Q2 2026.
- Cape Ann Savings Bank sold 100 AbbVie shares in Q2 2026, an estimated $21.5K.
- AbbVie made up 0.36% of Cape Ann Savings Bank's portfolio in Q2 2026, its #59 holding.
- Cape Ann Savings Bank first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Cape Ann Savings Bank's AbbVie position peaked at $2.05M in Q4 2023.
- 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cape Ann Savings Bank's 13F filing for Q2 2026, filed 4 Aug 2026.